KLA Corporation (KLAC) Q4 2025 10-Q Quarterly Report

Filed: Jan 30, 2026Period ending Dec 31, 2025
Health Care
Optical Instruments & LensesSEC EDGAR

KLA Corporation (KLAC) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Jan 30, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

KLA Corporation Q4 2025 10-Q Analysis

Management Discussion & Analysis

  • Working capital $7.28B Dec 2025, up $668.3M from $6.61B June 2025
  • Cash, cash equivalents, marketable securities $5.21B plus $1.50B Revolving Credit Facility availability
  • Liquidity sufficient for operations, capex, dividends, stock repurchases for next 12 months
  • Credit ratings: Fitch A, Moody’s A2, S&P A- as of Dec 31, 2025
  • No off-balance sheet arrangements materially affecting financial position or results

Risk Factors

  • New risk: 2025 BIS Rules and Affiliates Rule suspend/revised, expanding export controls and compliance complexity in China with suspension extended to Nov 2026
  • Updated regulatory risk: OBBBA tax law effective July 2025 modifies GILTI and FDII rules, materially affecting effective tax rate going forward
  • Highest impact legal risk: U.S. Export controls, including Oct 2023 and 2024-25 BIS incremental rules, severely restrict sales to China-based semiconductor companies, causing potential revenue disruption
  • Operational risk: DRAM chip shortages due to supplier discontinuations increased procurement costs, negatively impacting gross margin in calendar 2026
  • Financial risk: China sales declined to 33% of revenue in 2025 from 43% in 2024 due to export restrictions, risking revenue concentration and liquidity from lost orders

KLA Corporation Q4 2025 Quarterly Financials
XBRL

Revenue

$3.3B

+7.2% YoY +2.7% QoQ

Net Income

$1.1B

+39.0% YoY +2.2% QoQ

Net Margin

34.7%

+795bp YoY -18bp QoQ

ROE

21.0%

-204bp YoY

Total Assets

$16.7B

+11.5% YoY

EPS (Diluted)

$8.68

+40.9% YoY +2.5% QoQ

Operating Cash Flow

$1.4B

+61.0% YoY +17.7% QoQ

Source: XBRL data from KLA Corporation Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other KLA Corporation Quarterly Reports

Get deeper insights on KLA Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.